What the charts say.
Paratek Pharmaceuticals, Immunomedics and Intercept Pharmaceuticals were among the biotech stock movers in premarket trading Tuesday.
In highlights from this week's trading diary and posts, Kass offers some advice about fundamentals and about what earnings season means.
Intercept says it received approval from the FDA.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.